SUBJECTS : Vaccines | Hormones | | Diagnostics | Gene Therapies | Cytolog
Biologics: 2021, vol: 15, issue:
- 1)- Amit Sharma, Bithiah Grace Jaganathan. Stem Cell Therapy for Retinal Degeneration: The Evidence to Date. Biologics : targets & therapy. 2021, 15: 299-306
Cited : 29Read More - 2)- Thomas Müller. View Point: Disease Modification and Cell Secretome Based Approaches in Parkinson's Disease: Are We on the Right Track? Biologics : targets & therapy. 2021, 15: 307-316Cited : 0Read More
- 3)- Marta Kołt-Kamińska, Magdalena Żychowska, Adam Reich. Infliximab in Combination with Low-Dose Acitretin in Generalized Pustular Psoriasis: A Report of Two Cases and Review of the Literature. Biologics : targets & therapy. 2021, 15: 317-327Cited : 2Read More
- 4)- Yituo Xu, Zhijie Huang, Xingjuan Yu, Zhixiong Li, Limin Zheng, Jing Xu. HHLA2 Expression is Associated with Poor Survival in Patients with Hepatocellular Carcinoma. Biologics : targets & therapy. 2021, 15: 329-341Cited : 5Read More
- 5)- Kate E Findeisen, Julia Sewell, Andrew J K Ostor. Biological Therapies for Rheumatoid Arthritis: An Overview for the Clinician. Biologics : targets & therapy. 2021, 15: 343-352Cited : 12Read More
- 6)- Misganaw Asmamaw, Belay Zawdie. Mechanism and Applications of CRISPR/Cas-9-Mediated Genome Editing. Biologics : targets & therapy. 2021, 15: 353-361Cited : 97Read More
- 7)- Mario Cazzola, Josuel Ora, Francesco Cavalli, Paola Rogliani, Maria Gabriella Matera. An Overview of the Safety and Efficacy of Monoclonal Antibodies for the Chronic Obstructive Pulmonary Disease. Biologics : targets & therapy. 2021, 15: 363-374Cited : 8Read More
- 8)- Abdulaziz Madani, Qais Almuhaideb. Adalimumab Therapy in a Patient with Psoriasis, Down Syndrome, and Concomitant Hepatitis B Virus Infection. Biologics : targets & therapy. 2021, 15: 375-378Cited : 2Read More
- 9)- Najath Abdul Kareem, Ayesha Aijaz, Marc G Jeschke. Stem Cell Therapy for Burns: Story so Far. Biologics : targets & therapy. 2021, 15: 379-397Cited : 16Read More
- 10)- Marco Massafra, Maria Ilenia Passalacqua, Vittorio Gebbia, Paolo Macrì, Chiara Lazzari, Vanesa Gregorc, Carmelo Buda, Giuseppe Altavilla, Mariacarmela Santarpia. Immunotherapeutic Advances for NSCLC. Biologics : targets & therapy. 2021, 15: 399-417Cited : 8Read More
- 11)- Tareq Abuasab, Jacob Rowe, Ariella Tvito. Emerging Monoclonal Antibody Therapy for the Treatment of Acute Lymphoblastic Leukemia. Biologics : targets & therapy. 2021, 15: 419-431Cited : 1Read More
- 12)- Pedro Santos-Moreno, Susan Martinez, Linda Ibatá, Laura Villarreal, Manuel Rivero, Adriana Rojas-Villarraga. Certolizumab Can Also Be Effective in Monotherapy for the Treatment of Rheumatoid Arthritis Patients. Biologics : targets & therapy. 2021, 15: 433-440Cited : 1Read More
- 13)- Mimma Rizzo, Patrizia Giannatempo, Camillo Porta. Biological Therapeutic Advances for the Treatment of Advanced Urothelial Cancers. Biologics : targets & therapy. 2021, 15: 441-450Cited : 1Read More
- 14)- Debora Basile, Francesca Simionato, Alessandro Cappetta, Silvio Ken Garattini, Giandomenico Roviello, Giuseppe Aprile. State-of-the-Art of Monoclonal Antibodies for the Treatment of Gastric Cancer. Biologics : targets & therapy. 2021, 15: 451-462Cited : 2Read More
- 15)- Julia Berman, Victoria Furer, Mark Berman, Ofer Isakov, Devy Zisman, Amir Haddad, Ori Elkayam. Treatment with Ixekizumab Following Secukinumab Failure in Patients with Psoriatic Arthritis: Real-Life Experience from a Resistant Population. Biologics : targets & therapy. 2021, 15: 463-470Cited : 5Read More
